EGFR mutation testing and first line treatment of patients with advanced NSCLC and positive EGFR mutation status: results from a German registry.

31. Mai 2011

Eberhardt, W., Thomas, M., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, P., Zirrgiebel, U., Schütte, W., 2011.

EMCC / ESMO, European Multidisciplinary Cancer Congress, Stockholm (Poster 133), 664.